Bob Edwards

Bob Edwards is a seasoned Pharmaceutical Entrepreneur and Visionary with a successful track record in the pharmaceutical industry.

He has expertise in overseeing all aspects of pharmaceutical business including development, manufacturing, distribution, sales, and logistics.

With experience in negotiating deals with transactional bankers, private equity firms, and large corporations, Bob has a strong business acumen.

Currently, Bob Edwards is the founder and CEO of e5 Pharma, LLC and Mizner Bioscience, LLC.

He successfully sold a generic drug company that he co-founded to a publicly traded company.

Bob holds a Bachelor of Science (B.S.) degree in Business from Lynn University and is a U.S. Army Reserve Veteran.

In addition to his pharmaceutical career, Bob Edwards also owns and races Thoroughbred horses globally.

Starting with one NY Bred Thoroughbred, he has built a quality stable of equine athletes and achieved significant success in the past racing seasons.

His Racing stables have won multiple prestigious races, including 3 Breeders' Cup World Championships and fourteen Graded Stakes.

Bob Edwards is also known as a world-class breeder, having sold multiple horses for over USD 1M in the last year.

He holds a Masters of Science (M.S.) in Digital Innovation in Marketing from the Fox School of Business at Temple University.

Bob has held key positions in various organizations including CEO at e5 Pharma, LLC., Director on the Board of Directors at aptihealth, inc., and Board of Directors at Slync.io.

He was also the Founder of Mizner Bioscience, LLC, Owner of e Five Racing Thoroughbreds, LLC, CEO of Boca Pharmacal, Inc., and Generic Pharmaceutical Distributor at Aiko-Med, Inc.